DRTS — Alpha Tau Medical Share Price
Last trade - 00:00- $178.36m
- $102.18m
- 42
- 26
- 41
- 29
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.11 | ||
| Price to Tang. Book | 2.11 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -35.58% | ||
| Return on Equity | -30.67% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | 0.1 | 3.02 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 23rd, 2015
- Public Since
- March 8th, 2022
- No. of Shareholders
- 152
- No. of Employees
- 121
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 69,670,612
- Address
- Kiryat Hamada 5, JERUSALEM, 9777605
- Web
- https://www.alphatau.com/
- Phone
- +972 35774115
- Auditors
- Kost, Forer, Gabbay & Kasierer
Upcoming Events for DRTS
Similar to DRTS
1Sharpe Acquisition
NASDAQ Capital Market
5G Edge Acquisition
NASDAQ Capital Market
Able Brands Co
NASDAQ Capital Market
Acamar Partners Acquisition II
NASDAQ Capital Market
Ace Global Business Acquisition
NASDAQ Capital Market
FAQ
As of Today at 19:01 UTC, shares in Alpha Tau Medical are trading at $2.56. This share price information is delayed by 15 minutes.
Shares in Alpha Tau Medical last closed at $2.56 and the price had moved by -12.03% over the past 365 days. In terms of relative price strength the Alpha Tau Medical share price has underperformed the S&P500 Index by -26.79% over the past year.
The overall consensus recommendation for Alpha Tau Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Alpha Tau Medical does not currently pay a dividend.
Alpha Tau Medical does not currently pay a dividend.
Alpha Tau Medical does not currently pay a dividend.
To buy shares in Alpha Tau Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.56, shares in Alpha Tau Medical had a market capitalisation of $178.36m.
Here are the trading details for Alpha Tau Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: DRTS
Based on an overall assessment of its quality, value and momentum Alpha Tau Medical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alpha Tau Medical is $9.25. That is 261.33% above the last closing price of $2.56.
Analysts covering Alpha Tau Medical currently have a consensus Earnings Per Share (EPS) forecast of -$0.51 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alpha Tau Medical. Over the past six months, its share price has underperformed the S&P500 Index by -34.34%.
As of the last closing price of $2.56, shares in Alpha Tau Medical were trading -21.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alpha Tau Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.56.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Alpha Tau Medical's directors